Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13008032 | 0.93 | KDR (0.50) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL13008097 | 0.91 | KDR (0.54) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL31492034 | 0.89 | MAPT (0.50) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL469862 | 0.87 | KDR (0.48) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL31492062 | 0.86 | KDR (0.48) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL31492040 | 0.86 | KDR (0.46) | KDRCA1CA2CA12CA9 | |
| SCHEMBL31492121 | 0.85 | GAA (0.48) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL13061438 | 0.85 | KDR (0.51) | KDRCA1CA2CA12CA9 | |
| SCHEMBL469845 | 0.84 | AGTR1 (0.57) | KDRKMT2ACA1CA2CA12 | |
| SCHEMBL31492064 | 0.84 | KDR (0.50) | KDRKMT2ACA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025046420-A1 | COMPOUND TARGETING EGR-1 AND USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS | 주식회사 아제라메디 | 2025-03-06 | — | — | WO | disclosed |